Connor Lynch

438 total citations · 1 hit paper
14 papers, 213 citations indexed

About

Connor Lynch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Connor Lynch has authored 14 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Connor Lynch's work include Cancer Immunotherapy and Biomarkers (6 papers), Advanced Radiotherapy Techniques (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Connor Lynch is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Advanced Radiotherapy Techniques (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Connor Lynch collaborates with scholars based in United States, Germany and Philippines. Connor Lynch's co-authors include Sean P. Pitroda, Ralph R. Weichselbaum, Majid Mohiuddin, William F. Hartsell, Mingcheng Gao, Kaiting Yang, Liangliang Wang, András Piffkó, Hua Liang and Mahesh Gopalakrishnan and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Connor Lynch

12 papers receiving 211 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy, immunity, and immune checkpoint inhibitors

2024 58 citations Connor Lynch, Sean P. Pitroda et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Connor Lynch United States	5	81	65	45	44	42	14	213
Sylvain Dureau France	10	115 1.4×	47 0.7×	68 1.5×	38 0.9×	16 0.4×	19	214
JinYu Guo China	10	104 1.3×	137 2.1×	19 0.4×	57 1.3×	28 0.7×	37	285
Zeming Mo China	7	164 2.0×	113 1.7×	26 0.6×	78 1.8×	32 0.8×	11	369
Charleen Chan Wah Hak United Kingdom	5	66 0.8×	58 0.9×	132 2.9×	22 0.5×	88 2.1×	7	238
Denise N. Gansen United States	7	67 0.8×	66 1.0×	28 0.6×	37 0.8×	9 0.2×	8	272
D Jacqmin United States	8	87 1.1×	112 1.7×	16 0.4×	42 1.0×	116 2.8×	19	286
Vérane Achard Switzerland	10	87 1.1×	263 4.0×	71 1.6×	79 1.8×	52 1.2×	37	359
Daniel J. Craig United States	8	96 1.2×	50 0.8×	36 0.8×	51 1.2×	5 0.1×	13	191
Christelle Bouchart Belgium	10	142 1.8×	56 0.9×	80 1.8×	51 1.2×	6 0.1×	22	217
Brigitte C.M. Haberkorn Netherlands	11	191 2.4×	106 1.6×	77 1.7×	29 0.7×	15 0.4×	19	248

Countries citing papers authored by Connor Lynch

Since Specialization

Citations

This map shows the geographic impact of Connor Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Connor Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Connor Lynch more than expected).

Fields of papers citing papers by Connor Lynch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Connor Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Connor Lynch. The network helps show where Connor Lynch may publish in the future.

Co-authorship network of co-authors of Connor Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Connor Lynch. A scholar is included among the top collaborators of Connor Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Connor Lynch. Connor Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Huang, Daniel, Connor Lynch, Sean P. Pitroda, & Ralph R. Weichselbaum. (2025). Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease. Clinical Cancer Research. 31(13). 2556–2564. 2 indexed citations

Huang, Daniel, Connor Lynch, Randy F. Sweis, et al.. (2024). Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma. Clinical and Translational Radiation Oncology. 49. 100879–100879.

Lynch, Connor, Sean P. Pitroda, & Ralph R. Weichselbaum. (2024). Radiotherapy, immunity, and immune checkpoint inhibitors. The Lancet Oncology. 25(8). e352–e362. 58 indexed citations breakdown →

Lynch, Connor, Randy F. Sweis, Parth K. Modi, et al.. (2024). Bladder-Preserving Trimodality Therapy With Capecitabine. Clinical Genitourinary Cancer. 22(2). 476–482.e1.

Lynch, Connor, Mark Korpics, Rohan Katipally, et al.. (2024). Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1519–1530. 3 indexed citations

Lynch, Connor, et al.. (2024). Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease. Journal of Clinical Oncology. 42(29). 3387–3391. 1 indexed citations

Lynch, Connor, Mark Korpics, Rohan Katipally, et al.. (2024). Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials. European Journal of Cancer. 209. 114264–114264. 4 indexed citations

Ballas, Leslie K., Antonio Franco, Connor Lynch, et al.. (2024). Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Two-year quality of life and toxicity outcomes of a multicenter phase II trial.. Journal of Clinical Oncology. 42(4_suppl). 317–317. 1 indexed citations

Wang, Liangliang, Connor Lynch, Sean P. Pitroda, et al.. (2024). Radiotherapy and immunology. The Journal of Experimental Medicine. 221(7). 46 indexed citations

10.

Spurr, Liam F., Carlos Alberto Martínez, Woojin Kang, et al.. (2023). Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC. International Journal of Radiation Oncology*Biology*Physics. 117(2). S23–S23. 1 indexed citations

11.

Lynch, Connor, et al.. (2022). Developing a CBCT-Guided Online Adaptive Radiotherapy Approach for Isotoxic Delivery of Ultra-High Dose to Oligometastatic Disease in Combination with Immunotherapy. International Journal of Radiation Oncology*Biology*Physics. 114(3). e594–e594. 1 indexed citations

12.

Gross, Jeffrey P., Connor Lynch, Sumanas W. Jordan, et al.. (2019). Determining the Organ at Risk for Lymphedema After Regional Nodal Irradiation in Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(3). 649–658. 33 indexed citations

13.

Mohiuddin, Majid, Connor Lynch, Mingcheng Gao, & William F. Hartsell. (2019). Early clinical results of proton spatially fractionated GRID radiation therapy (SFGRT). British Journal of Radiology. 93(1107). 20190572–20190572. 34 indexed citations

14.

Jiang, Dadi, Connor Lynch, Bruno C. Medeiros, et al.. (2016). Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response. Scientific Reports. 6(1). 33353–33353. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact